Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/cbic.202000250 http://scihub22266oqcxt.onion/10.1002/cbic.202000250 32367615!7687022!32367615     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Chembiochem 2020 ; 21 (20): 2880-2889 Nephropedia Template TP {{tp|p=32367615|t=2020. Trends and Innovations in Biosensors for COVID-19 Mass Testing |pdf=|usr=}}{{32367615}} gab.com Text Trends and Innovations in Biosensors for COVID-19 Mass Testing JO: Chembiochem http://www.kidney.de/pget.php?&tw=1&pmid=32367615 #FOAvip Fast and widespread diagnosis is crucial to fighting against the outbreak of COVID-19. This work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative reverse transcription polymerase chain reaction are used in most clinical laboratories. However, the COVID-19 pandemic has overwhelmed testing capacity and motivated the development of fast point-of-care tests and the adoption of isothermal DNA amplification. Antigenic and serological rapid tests based on lateral-flow immunoassays suffer from low sensitivity. Advanced digital systems enhance performance at the expense of speed and the need for large equipment. Emerging technologies, including CRISPR gene-editing tools, benefit from high sensitivity and specificity of molecular diagnostics and the easy use of lateral-flow assays. DNA sequencing and sample pooling strategies are highlighted to bring out the full capacity of the available biosensor technologies and accelerate mass testing. Twit Text FOAVip Trends and Innovations in Biosensors for COVID-19 Mass Testing ????Chembiochem http://www.kidney.de/pget.php?&tw=1&pmid=32367615 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32367615 #FOAvip English Wikipedia <ref>{{Cite pmid|32367615}}</ref> Trends and Innovations in Biosensors for COVID-19 Mass Testing #MMPMID32367615 Santiago I Chembiochem 2020[Oct]; 21 (20): 2880-2889 PMID32367615show ga Fast and widespread diagnosis is crucial to fighting against the outbreak of COVID-19. This work surveys the landscape of available and emerging biosensor technologies for COVID-19 testing. Molecular diagnostic assays based on quantitative reverse transcription polymerase chain reaction are used in most clinical laboratories. However, the COVID-19 pandemic has overwhelmed testing capacity and motivated the development of fast point-of-care tests and the adoption of isothermal DNA amplification. Antigenic and serological rapid tests based on lateral-flow immunoassays suffer from low sensitivity. Advanced digital systems enhance performance at the expense of speed and the need for large equipment. Emerging technologies, including CRISPR gene-editing tools, benefit from high sensitivity and specificity of molecular diagnostics and the easy use of lateral-flow assays. DNA sequencing and sample pooling strategies are highlighted to bring out the full capacity of the available biosensor technologies and accelerate mass testing. |*Betacoronavirus[MESH] |Biosensing Techniques/*methods/trends[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques[MESH] |Coronavirus Infections/*diagnosis[MESH] |Diagnostic Tests, Routine/*methods/trends[MESH] |Humans[MESH] |Immunoassay/methods[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis[MESH] |Real-Time Polymerase Chain Reaction[MESH]Trends and Innovations in Biosensors for COVID-19 Mass Testing (epmc).pdf DeepDyve Pubget Overpricing